You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Type 2 Inflammation

Cumulative Exposure to Corticosteroids in Type 2 Inflammatory Diseases

Dr. Evan Dellon highlights potential risks with cumulative use of steroids for treatment of various coexisting type 2 inflammatory diseases.

Evan  Dellon
Evan Dellon

Learning objectives

  • Recognize the potential for complications with cumulative exposure to steroid treatment of coexisting diseases with underlying type 2 inflammation


Join global expert Evan Dellon, MD, MPH, as he highlights different ways that corticosteroids may be taken by a patient for various type 2 inflammatory diseases, and discusses the cumulative risk for steroid complications.

MAT-GLB-2102867 v2.0 07/2021

About this expert


Evan Dellon


Professor of Medicine and Adjunct Professor of Epidemiology | University of North Carolina School of Medicine, Chapel Hill, United States

See author’s profile
Evan  Dellon

Related resources